SCHEMBL21687986

SCHEMBL21687986

N#Cc1ccccc1[Si](c1ccccc1)(c1ccccc1)c1ccccc1-c1ccc(-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ESR2 Q92731 1/20 0.35
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
NR3C1 P04150 1/20 0.33
MEN1 O00255 1/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HDAC4 P56524 1/20 0.33
MAPT P10636 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
PPARG P37231 2/20 0.32
IMPDH2 P12268 1/20 0.31
TRPA1 O75762 1/20 0.31
PDE10A Q9Y233 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21688035 0.92 NR3C1 (0.33) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL21688082 0.89 KDM4E (0.42) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL21687995 0.88 NR3C1 (0.35) ESR2ALDH1A1SMN1; SMN2NR3C1LMNA
SCHEMBL21687461 0.87 KDM4E (0.37) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL21688221 0.86 ATM (0.40) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL21687460 0.86 ESR2 (0.35) KDM4EATML3MBTL1ESR2ALDH1A1
SCHEMBL21687969 0.84 KDM4E (0.41) KDM4EATML3MBTL1ESR2ALDH1A1
SCHEMBL21688085 0.84 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL21687830 0.83 ALDH1A1 (0.35) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL21687544 0.82 KDM4E (0.41) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.